Escalade (ESCA)
(Real Time Quote from BATS)
$13.64 USD
-0.01 (-0.07%)
Updated Sep 20, 2024 01:30 PM ET
5-Strong Sell of 5 5
B Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Escalade, Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 264 | 314 | 314 | 274 | 181 |
Cost Of Goods | 202 | 240 | 236 | 199 | 138 |
Gross Profit | 62 | 74 | 77 | 75 | 42 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 47 | 45 | 42 | 33 |
Income After Depreciation & Amortization | 18 | 26 | 32 | 33 | 9 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 5 | 4 | 2 | 0 | 0 |
Pretax Income | 12 | 23 | 31 | 33 | 9 |
Income Taxes | 3 | 5 | 6 | 7 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 10 | 18 | 24 | 26 | 7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 10 | 18 | 24 | 26 | 7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 23 | 32 | 37 | 37 | 13 |
Depreciation & Amortization (Cash Flow) | 6 | 6 | 5 | 4 | 4 |
Income After Depreciation & Amortization | 18 | 26 | 32 | 33 | 9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 13.84 | 13.73 | 13.87 | 14.10 | 14.52 |
Diluted EPS Before Non-Recurring Items | 0.71 | 1.31 | 1.76 | 1.82 | 0.50 |
Diluted Net EPS (GAAP) | 0.71 | 1.31 | 1.76 | 1.82 | 0.50 |
Fiscal Year end for Escalade, Incorporated falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 62.53 | 57.30 | 65.51 | 73.36 | 67.77 |
Cost Of Goods | 47.42 | 42.95 | 49.57 | 55.22 | 51.12 |
Gross Profit | 15.11 | 14.35 | 15.94 | 18.14 | 16.65 |
SG&A, R&D, and Dept/Amort Expenses | 10.65 | 11.29 | 10.98 | 11.69 | 10.39 |
Income After SG&A, R&D, and Dept/Amort Expenses | 4.46 | 3.06 | 4.96 | 6.45 | 6.26 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Interest Expense | 0.73 | 0.74 | 1.07 | 1.33 | 1.58 |
Pretax Income | 3.73 | 2.33 | 3.89 | 5.13 | 4.69 |
Income Taxes | 0.89 | 0.55 | 1.03 | 0.85 | 1.04 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 2.84 | 1.78 | 2.86 | 4.28 | 3.64 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 2.84 | 1.78 | 2.86 | 4.28 | 3.64 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 13.54 | 13.65 | 13.64 | 13.79 | 13.49 |
Diluted EPS Before Non-Recurring Items | 0.20 | 0.13 | 0.21 | 0.31 | 0.26 |
Diluted Net EPS (GAAP) | 0.20 | 0.13 | 0.21 | 0.31 | 0.26 |